Skip to main content
AtriCure, Inc. logo

AtriCure, Inc. — Investor Relations & Filings

Ticker · ATRC ISIN · US04963C2098 LEI · 254900B2I6GPHK2EXM59 US Manufacturing
Open in API
Filings indexed 1,189 across all filing types
Latest filing 2015-01-28 Director's Dealing
Country US United States of America
Listing US ATRC

About AtriCure, Inc.

https://www.atricure.com

AtriCure, Inc. is a medical device company focused on developing, manufacturing, and selling technologies for the treatment of atrial fibrillation (Afib), management of the left atrial appendage (LAA), and post-operative pain. The company's product portfolio is primarily utilized by cardiothoracic surgeons and electrophysiologists. Key offerings include surgical ablation systems and the AtriClip® LAA Exclusion System, a widely implanted device for LAA management. Additionally, AtriCure provides cryoablation technology, such as the cryoXT™ Probe, which offers a non-opioid approach to pain management following surgical procedures, including amputation.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2015-01-28 English
FORM 4 SUBMISSION
Director's Dealing
2015-01-28 English
Major Shareholding Notification 2015
Major Shareholding Notification
2015-01-22 English
Major Shareholding Notification 2015
Major Shareholding Notification
2015-01-22 English
CURRENT REPORT
Board/Management Information Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated January 14, 2015. The content focuses on the appointment of a new Chief Operating Officer, Douglas J. Seith, and mentions his background and compensation eligibility. There is no financial data, earnings information, or detailed report content. The primary subject is a change in senior management. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). The document length is 2878 characters, which is relatively short and consistent with a management change announcement rather than a full report. Therefore, the appropriate classification is MANG with high confidence.
2015-01-14 English
CURRENT REPORT
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated January 12, 2015. It includes a press release with preliminary financial results for the fourth quarter and full year ended December 31, 2014, and an investor presentation discussing the company's business and growth strategy. The document explicitly states that the press release and presentation are furnished as exhibits and incorporated by reference, and the information is being furnished, not filed, indicating this is an announcement rather than the full financial report itself. The document length is 4430 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, according to the "Menu vs Meal" rule, this document is best classified as a Regulatory Filing (RNS) because it is a current report announcing financial results and an investor presentation, not the full earnings release or annual/interim report itself.
2015-01-12 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.